Intended for US audiences only.

Join IgCares

*All fields required unless indicated otherwise

Contact Information Patient Therapy Information Patient Services Program Consent Agreement

Contact Information

Patient Therapy Information

Patient Services Enrollment

I would like to:

Please review the following terms

Indications and Important Safety Information for cutaquig® (Immune Globulin Subcutaneous (Human) - hipp), 16.5% solution
Warning: Thrombosis
See cutaquig’s full prescribing information for complete boxed warning
Thrombosis may occur with immune globulin products, including cutaquig.
CUTA-0125